Evidence map›Paper›PMID 10597240›Full record

ArticleOncogene1999

Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.

N Darbinian, G L Gallia, M Kundu, N Shcherbik, A Tretiakova, A Giordano, K Khalili

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. The RB/E2F pathway and regulation of RNA processing.Biochemical and biophysical research communications · 2009
    Review
  11. Review
  12. Protective role of Puralpha to cisplatin.Cancer biology & therapy · 2008
    Article
  13. Article
  14. Article
  15. Review
  16. Association of HIV-1 Tat with the cellular protein, Puralpha, is mediated by RNA.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

N DarbinianCenter for NeuroVirology and NeuroOncology, MCP Hahnemann University School of Medicine, Philadelphia, PA 19102, USA.
G L Gallia
M Kundu
N Shcherbik
A Tretiakova
A Giordano
K Khalili
Hahnemann University Hospital · USThomas Jefferson University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-protein interaction can play an important role in the control of several biological events including gene transcription, replication and cell proliferation. E2F-1 is a DNA-binding transcription factor which, upon interaction with its target DNA sequence, induces expression of several S phase specific genes allowing progression of the cell cycle. Evidently, the activity of this protein is modulated by its cellular partner, pRb, which in the hypophosphorylated form, binds to E2F-1 and inactivates its transcriptional ability. In this study, we have demonstrated that expression of a sequence-specific single-stranded DNA binding protein, Pur alpha, in cells decreases the ability of E2F-1 to exert its transcriptional activity upon the responsive promoter derived from DHFR. Results from band shift experiments revealed that while Pur alpha does not recognize the double-stranded DNA fragment containing the E2F-1 binding site, it has the ability to inhibit E2F-1 interaction with its target DNA sequence. Results from GST pull-down assays and the combined immunoprecipitation/Western blot analysis of nuclear extracts revealed a direct association of E2F-1 with Pur alpha in the absence of the DNA molecule containing the E2F-1 binding site. The association of Pur alpha with E2F-1 may increase the stability of E2F-1, as a higher level of E2F-1 was detected in cells coexpressing Pur alpha and E2F-1. The importance of these observations with respect to the role of Pur alpha in the control of cell cycle progression is discussed.

Indexed as

Carrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsTranscription, GeneticAstrocytesBinding SitesCell CycleCell-Free SystemCell LineConsensus SequenceCyclic AMP Response Element-Binding ProteinDNA, Single-StrandedE2F1 Transcription FactorE2F Transcription FactorsGenes, ReporterHumansCarrier ProteinsCell Cycle ProteinsCyclic AMP Response Element-Binding ProteinDNA-Binding ProteinsDNA, Single-StrandedE2F1 protein, humanE2F1 Transcription FactorE2F Transcription FactorsPURA protein, humanRecombinant Fusion ProteinsRetinoblastoma-Binding Protein 1Retinoblastoma ProteinTetrahydrofolate DehydrogenaseTranscription Factor DP1Transcription Factors

Identifiers

PMID10597240
OpenAlexW2323137403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.